Skip to main content
. 2021 Oct 16;36(8):2536–2543. doi: 10.1053/j.jvca.2021.10.015

Table 1.

Parameter-all in citrate Full Name Additives Interpretation Clinical use
CK- R Reaction time Kaolin Coagulation function Anticoagulation or coagulopathy
CK-MA Maximum amplitude Kaolin Platelets and fibrinogen clot strength Sensitive to prolonged R time
CRT-MA Maximum amplitude Tissue factor (TF) Platelets and fibrinogen clot strength Rapid resulting; less sensitive to prolonged R time
CKH-R Reaction time Heparinase Coagulation with heparin neutralized Diagnose heparin effect
CFF-MA Functional fibrinogen TF+Abciximab Fibrinogen function Rapid resulting, specific
Platelet mapping MA-ADP Maximum amplitude to ADP ADP Platelet response to ADP agonist Clopidogrel and other P2Y12 blockers
Platelet mapping % inhibition % inhibition ADP Calcuated from MA-ADP Anti-platelet therapies